Peer Review Committee for Immunology and Blood Cell Development (IBCD)
Areas Reviewed
- Immune responses to cancer including active and passive immune therapies for cancer, adoptive transfer of autologous or allogeneic hematopoietic cells, and targeted delivery of toxic payloads
- Immune tolerance and hematopoiesis
- Molecular, structural, biochemical, and biophysical aspects of the immune system including cell types, cytokines, antigen processing, antibody molecules, and deficiencies
Committee members are being determined and will be announced early 2021.